New Player Comes Into Lykos Sphere…Brit Hedge Fund Guy Sir Christopher Hohn… Psychedelic Alpha Calls Him, “ruthless activist investor.”

Psychedelic Alpha reports In January, we reported on billionaire investor Antonio Gracias’ bid to take control of embattled MDMA drug developer Lykos Therapeutics. Now, Gracias appears to be teaming up with an unlikely co-investor. Psychedelic Alpha understands that the Musk associate and DOGE advisor is joined by an even deeper-pocketed individual: Sir Christopher Hohn. The British decabillonaire investment manager and […]